Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

137.99
-4.7800-3.35%
Post-market: 136.53-1.4600-1.06%19:59 EDT
Volume:25.82M
Turnover:3.54B
Market Cap:55.09B
PE:-17.23
High:138.80
Open:137.19
Low:133.33
Close:142.77
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.60
T/O Rate:7.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.15
PE(LYR):-19.01

Loading ...

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Yesterday

US Stocks Weekly: AI Refuel

Reuters
·
Yesterday

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Yesterday

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Yesterday

Top Calls On Wall Street: Nvidia, SpaceX, Moderna, TeraWulf , Amazon,Marvell, and More

Tiger Newspress
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Movement Alert|Moderna, Inc. Falls 4.41% in Regular Trading, Convertible Note Offering Upsized to $2.6 Billion Intensifies Dilution Concerns

Market Focus
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Reuters
·
Aug 28

Movement Alert|Moderna, Inc. Rises 3.31% in Pre-Market Trading, Updated Spikevax Vaccine Approval Expands Eligible Population

Market Focus
·
Aug 28

U.S. Research Roundup-Dollar General, Palo Alto, Workday

Reuters
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Dow Jones
·
Aug 28

Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant

Reuters
·
Aug 28

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS
·
Aug 28